(MED) MEDICLIN Aktiengesellschaft - Ratings and Ratios
Exchange: XETRA • Country: Germany • Currency: EUR • Type: Common Stock • ISIN: DE0006595101
MED: Hospital, Medical, Rehabilitation, Nursing, Outpatient, Care
MEDICLIN Aktiengesellschaft operates hospitals in Germany. The company operates through Post-Acute, Acute, and Other Activities segments. It offers medical services in the areas of neurology, psychosomatics, orthopedics, internal medicine, cardiology, oncology, geriatrics, psychiatry, vascular medicine, otorhinolaryngology, cardiac medicine, rheumatology, pain medicine, trauma surgery, urology, and others. The company also provides services in the areas of ENT and acute outpatient services. It owns clinics, rehabilitation care, nursing care facilities, and medical care centers in German federal states. The company was incorporated in 1994 and is headquartered in Offenburg, Germany. Web URL: https://www.mediclin.de
Additional Sources for MED Stock
MED Stock Overview
| Market Cap in USD | 118m |
| Sector | Healthcare |
| Industry | Medical Care Facilities |
| GiC Sub-Industry | Health Care Facilities |
| IPO / Inception |
MED Stock Ratings
| Growth 5y | -83.9% |
| Fundamental | 60.5% |
| Dividend | 4.54% |
| Rel. Strength Industry | -682 |
| Analysts | - |
| Fair Price Momentum | 1.89 EUR |
| Fair Price DCF | 17.49 EUR |
MED Dividends
| Dividend Yield 12m | 0.00% |
| Yield on Cost 5y | % |
| Annual Growth 5y | 0.00% |
| Payout Consistency | 15.1% |
MED Growth Ratios
| Growth Correlation 3m | -0.4% |
| Growth Correlation 12m | -53.5% |
| Growth Correlation 5y | -95.5% |
| CAGR 5y | -18.32% |
| CAGR/Mean DD 5y | -0.49 |
| Sharpe Ratio 12m | -0.24 |
| Alpha | -13.54 |
| Beta | -0.06 |
| Volatility | 28.56% |
| Current Volume | 0k |
| Average Volume 20d | 3.4k |
What is the price of MED stocks?
As of January 22, 2025, the stock is trading at EUR 2.42 with a total of 0 shares traded.
Over the past week, the price has changed by +0.83%, over one month by -1.63%, over three months by +1.68% and over the past year by -9.70%.
As of January 22, 2025, the stock is trading at EUR 2.42 with a total of 0 shares traded.
Over the past week, the price has changed by +0.83%, over one month by -1.63%, over three months by +1.68% and over the past year by -9.70%.
Is MEDICLIN Aktiengesellschaft a good stock to buy?
Yes, based on ValueRay Fundamental Analyses, MEDICLIN Aktiengesellschaft (XETRA:MED) is currently (January 2025) a good stock to buy. It has a ValueRay Fundamental Rating of 60.45 and therefor a positive outlook according to the companies health.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of MED as of January 2025 is 1.89. This means that MED is currently overvalued and has a potential downside of -21.9%.
Yes, based on ValueRay Fundamental Analyses, MEDICLIN Aktiengesellschaft (XETRA:MED) is currently (January 2025) a good stock to buy. It has a ValueRay Fundamental Rating of 60.45 and therefor a positive outlook according to the companies health.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of MED as of January 2025 is 1.89. This means that MED is currently overvalued and has a potential downside of -21.9%.
Is MED a buy, sell or hold?
MEDICLIN Aktiengesellschaft has no consensus analysts rating.
MEDICLIN Aktiengesellschaft has no consensus analysts rating.
What are the forecast for MED stock price target?
According to ValueRays Forecast Model, MED MEDICLIN Aktiengesellschaft will be worth about 2.1 in January 2026. The stock is currently trading at 2.42. This means that the stock has a potential downside of -11.57%.
According to ValueRays Forecast Model, MED MEDICLIN Aktiengesellschaft will be worth about 2.1 in January 2026. The stock is currently trading at 2.42. This means that the stock has a potential downside of -11.57%.
| Issuer | Forecast | Upside |
|---|---|---|
| Wallstreet Target Price | 4.8 | 96.3% |
| Analysts Target Price | - | - |
| ValueRay Target Price | 2.1 | -11.6% |